Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1001
-0.0379
(-27.46%)
At close: March 28 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 25.88M | 29.89M | 122.47M | 207.03M |
| Low Estimate | 13.5M | 14.4M | 59.48M | 62.45M |
| High Estimate | 52.11M | 54.28M | 217.11M | 458.58M |
| Year Ago Sales | 10.88M | 16.37M | 56.59M | 122.47M |
| Sales Growth (year/est) | 137.75% | 82.62% | 116.42% | 69.05% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SCLXW | -- | -- | -- | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Related Tickers
EH3A.F Amarin Corporation plc
0.3500
-2.23%
AMRN Amarin Corporation plc
0.4420
-1.36%
GSK.L GSK plc
1,423.50
-3.10%
GSK GSK plc
37.87
-2.25%
GILD Gilead Sciences, Inc.
111.28
-0.69%
LLY Eli Lilly and Company
805.23
-2.50%
NOVO-B.CO Novo Nordisk A/S
468.25
-2.24%
NVO Novo Nordisk A/S
68.03
-2.03%
MRK Merck & Co., Inc.
87.12
-2.94%
JNJ Johnson & Johnson
153.25
-7.59%